While the bulk of CureVac's prize money will go to
basic molecular
immunology research, Hoerr says he also wants to set aside a portion to pay tribute to Miescher, the biologist from Switzerland who identified nucleic acids, a family of key biological molecules that includes DNA and RNA, in his
lab in Tübingen.